Page 101 - Puneet Wadhwa/undefined

Negative bias on precious metals in short run: C P Krishnan

Interview with Wholetime director, Geojit Comtrade

Cong manifesto: Hidebound & high cost, say Analysts

BJP, the key opponent, is yet to issue its manifesto but it is believed the party might refrain from mentioning the contentious issue of job reservation

Markets may remain at elevated levels: Dilip Bhat

Interview with Joint Managing Director, Prabhudas Lilladher Group

PSU stocks surge. Should you buy?

Analysts believe these stocks have more headroom but one has to be careful while investing

Gas price hike postponement is a short-term negative: analysts

Despite the near-term concerns, analysts expect the next government to hike prices after assuming charge in May

Delivery-based volumes near a year's high

Average monthly stock delivery volumes on the BSE, NSE have risen to 45.5% in Feb, the highest since March 2013

Fund managers take risk-off stance: BofA-ML

Though investors see value in emerging markets, they have scaled down expectations of a vibrant recovery in corporate profit growth

Are IT stocks a good contrarion bet?

Analysts are still positive about the sector, say business growth will pick up going ahead

Sun Pharma: Minimal impact of US FDA action

The recent import alert should not imply any read-through for its other facilities, analysts say

India remains a favourite for FIIs

Positive sentiment on expectations of a Modi-led NDA victory puts India ahead of other poll-bound emerging markets

Is the tide turning for cyclical stocks?

Analysts expect momentum to continue but say a progressive govt will be key

Equities have potential to deliver superior returns: Sukumar Rajah

Interview with MD & chief investment officer (Asian equity and local asset management), Franklin Templeton

Markets to carry upward pre-poll bias, say experts

Experts find valuations comforting, with most frontline indices and mid- and small-cap companies trading at historically low valuations

Large-caps fare better than SMEs in first 9 months of FY14

The hardest hit have been companies with sales less than Rs 100 crore, with their profits declining from Rs 413 crore in April-December 2012 to a cumulative loss of Rs 1,113 crore in the first nine mo

Pharma stocks on a booster dose

Better-than-expected financial results in Q3 due to higher revenue growth and margins in key markets fuel the rally

Advantage Tata Power, pain for NTPC

Tata Power surges 5%; NTPC slumps to five-year low

Indian investors have been completely wrong in the past five years: Samir Arora

Interview with Founder & Fund Manager, Helios Capital

Stocks of banking licence aspirants in focus

L&T Finance Holdings, LIC Housing Finance, Indiabulls Housing Finance, Magma Fincorp ended 3-4% higher

Investors shy from FMCG

Investors have preferred to cling on to stocks from the IT and pharmaceutical space in a volatile market

Power stocks react to CERC orders. Should you buy?

NTPC slumps to five-year low; Tata Power surges 5%